ENSAYO MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO, DE GRUPOS PARALELOS Y COMPARATIVO CON UN CONTROL ACTIVO Y PLACEBO DE BAY 1753011, UN ANTAGONISTA DUAL DE LOS RECEPTORES V1A/V2 DE LA VASOPRESINA, EN PACIENTES CON INSUFICIENCIA CARDÍACA CONGESTIVA. ENSAYO AVANTI.

Article. 10.1007/s40292-021-00476-4. 2021

Adoptive transfer of ex-vivo expanded SARS-CoV-2-specific Cytotoxic Lymphocytes: a viable strategy for COVID-19 immunosuppressed patients?

Guerreiro M; (...); Piñana JL

Article. 10.1111/tid.13602. 2021

Alpha-cardiac Actin Serum Expression Levels Detect Acute Cellular Rejection in Heart Transplant Patients.

Perez-Carrillo, Lorena; (...); Rosello-Lleti, Esther

Article. 10.1097/TP.0000000000004273. 2022

Alterations in the Nucleocytoplasmic Transport in Heart Transplant Rejection.

Lozano-Edo, Silvia; (...); Martinez-Dolz, Luis

Article. 10.1016/j.transproceed.2021.09.003. 2021

Analysing criteria for price and reimbursement of orphan drugs in Spain.

Badia, X; (...); Tort, M

Article. 10.7399/fh.11147. 2019

Analysis of complications in patients with ECMO as a bridge to transplantation since the beginning of the technique (2007-2023)

Guerrero Cervera, Borja; (...); Almenar Bonet, Luis

Meeting Abstract. 2024

Analysis of chemical contamination by hazardous drugs with BD HD Check(R) system in a tertiary hospital

Valero García S; (...); Poveda Andrés JL

Article. 10.1177/10781552211038518. 2021

Analysis of Heart Transplant Survival According to Difference in Age Between Donor and Recipient.

Article. 10.1016/j.transproceed.2022.10.014. 2022

Analysis of heart transplantation survival according to difference in age between donor and recipient

Donoso Trenado, V.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

Analysis of the implantation of heart failure with reduced ejection fraction treatment in clinical practice and its impact on achieving target doses

Esteban Fernandez, A. Alberto; (...); Fernandez, V. Alonso

Meeting Abstract. 2023

Analysis of the Intrahospital and Long-Term Survival of Heart Transplant Patients With a Short-Term Mechanical Assistance Device.

Lopez-Vilella, Raquel; (...); Bonet, Luis Almenar

Article. 10.1016/j.transproceed.2021.06.030. 2021

Analytical Evaluation of ABL90 Flex Plus Blood Gas Analyzer for Urea and Creatinine Multicenter Method Comparison

Sanchez, CP; (...); Soto, AB

Article. 10.1097/POC.0000000000000200. 2020

Annual evolution of the prescription of drugs with prognostic implications in acute decompensated heart failure with reduced ejection fraction.

Article. 10.1186/s12872-024-03728-y. 2024

Anti-endotoxin antibodies consumption in cardiovascular collapse: Pathophysiological concerns.

Villarreal, E.; (...); Vila, J.

Article. 10.1016/j.medine.2022.04.019. 2022

Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA).

Pereyra-Rodríguez JJ; (...); Ortiz de Frutos FJ

Letter. 10.1111/jdv.19432. 2023

Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.

Iglesias Gómez R; (...); Poveda Andrés JL

Article. 10.1136/ejhpharm-2021-002741. 2021

Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.

Fernandez Rivera C; (...); Hernandez D

Article. 10.1111/ctr.14550. 2022

Bridge to cardiac transplantation with temporary mechanical circulatory support: trends and outcomes in Spain (2010-2020)

Barge Caballero, E. Eduardo; (...); Crespo-Leiro, M.

Meeting Abstract. 2022

Can we start quadruple therapy in new-diagnosed heart failure patients in real life? Insights into the basal characteristics of TIDY-HF register

Esteban Fernandez, A.; (...); Torres Lego, J.

Meeting Abstract. 2022

Cardiac Allograft Rejection Induces Changes in Nucleocytoplasmic Transport: RANGAP1 as a Potential Non-Invasive Biomarker.

Lozano-Edo, Silvia; (...); Martinez-Dolz, Luis

Article. 10.3390/jpm12060913. 2022

Cardiac S1P/Ceramide imbalance in human heart failure: implication of gene dysregulation

Perez Carrillo, L.; (...); Tarazon, E.

Meeting Abstract. 2021

Cardiovascular Events during and after Bronchiectasis Exacerbations and Long-Term Mortality.

Méndez R; (...); Menéndez R

Article. 10.1016/j.chest.2021.10.013. 2021

Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy.

Alania-Torres, Edgardo; (...); Valle-Munoz, Alfonso

Case Reports. 10.3389/fcvm.2021.759119. 2021

CCSER2 and RAC3 serum expression levels detect cardiac allograft rejection

Rodriguez, J. M.; (...); Rosello-Lleti, E.

Meeting Abstract. 2021

Circulating long non-coding RNAs detection after heart transplantation and its accuracy in the diagnosis of acute cardiac rejection.

Pérez-Carrillo L; (...); Roselló-Lletí E

Letter. 10.1186/s40364-024-00590-0. 2024

Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients

Megias-Vericat, JE; (...); Poveda, JL

Article. 10.1016/j.thromres.2021.07.009. 2021

Clinical pharmacy services: from cost-effectiveness analysis to a productivity indicators model

Nogueras, A; (...); Calleja, MA

Letter. 10.1136/ejhpharm-2019-001905. 2019

Clinical phenotypes according to diuretic combination in acute heart failure.

Article. 10.1016/j.hjc.2023.03.009. 2023

Clinical profile of an unselected population with heart failure treated with vericiguat in real life: differences with the VICTORIA trial

Esteban-Fernandez, Alberto; (...); VERISEC Registry Researchers

Article. 10.3389/fcvm.2024.1504427. 2025

Clinical profile of heart failure patients starting vericiguat in clinical practice

Esteban Fernandez, A. Alberto; (...); Diez Villanueva, P.

Meeting Abstract. 2024

Clinical profiling of patients admitted with acute heart failure: a comprehensive survival analysis.

Article. 10.3389/fcvm.2024.1381514. 2024

Clinical utility and safety of finerenone in patients with heart failure: Rationale and design of FINE registry.

Alonso Salinas, Gonzalo Luis; (...); Diez-Villanueva, Pablo

Article. 10.1002/ehf2.15260. 2025

Clinical, echocardiographic and analytical patterns of biomarkers in cardiac amyloidosis; a real-world analysis.

Lopez Vilella, R. Raquel; (...); Almenar Bonet, L.

Meeting Abstract. 2024

Cold ischemia >4 hours increases heart transplantation mortality. An analysis of the Spanish heart transplantation registry

Valero-Masa, MJ; (...); Martinez-Selles, M

Article. 10.1016/j.ijcard.2020.06.009. 2020

Combining Serum miR-144-3p and miR-652-3p as Potential Biomarkers for the Early Diagnosis and Stratification of Acute Cellular Rejection in Heart Transplantation Patients.

Pérez-Carrillo L; (...); Roselló-Lletí E

Article. 10.1097/TP.0000000000004622. 2023

Combining serum miR-144-3p and miR-652-3p as potential biomarkers for the early diagnosis and stratification of acute cellular rejection in heart transplantation patients

Perez-Carrillo, L.; (...); Rosello-Lleti, E.

Meeting Abstract. 2022

Community acquired respiratory virus infections in adult patients undergoing umbilical cord blood transplantation.

Montoro J; (...); Piñana JL

Article. 10.1038/s41409-020-0943-0. 2020

Community-Acquired Pneumonia Patients at Risk for Early and Long-term Cardiovascular Events Are Identified by Cardiac Biomarkers

Menendez, R; (...); Torres, A

Article. 10.1016/j.chest.2019.06.040. 2019

COMPARATIVE ANALYSIS OF SURVIVAL OF PATIENTS WITH CONGENITAL HEART DISEASE TRANSPLANTED FROM HEART OR HEART-LUNG

Trenado, VD; (...); Almenar-Bonet, L

Meeting Abstract. 2021

Comparative Temporal Analysis of Morbidity and Early Mortality in Heart Transplantation with Extracorporeal Membrane Oxygenation Support: Exploring Trends over Time

Article. 10.3390/biomedicines12092109. 2024

Comparison of pharmacokinetic estimates using generic and specific population pharmacokinetic models of plasma-derived factor VIII/VWF using WAPPS-Hemo

Megias-Vericat, JE; (...); Poveda, JL

Meeting Abstract. 2020

Complications After Heart Transplantation According to the Type of Pretransplant Circulatory/Ventricular Support.

Lopez-Vilella, R; (...); Bonet, LA

Article. 10.1016/j.transproceed.2021.08.040. 2021

Comprehensive survival analysis in acute heart failure: profiling patients through clinical examination at admission

Raquel Lopez Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2024

Consensus on the management of hyperkalemia in patients with heart failure: recommendations from the SEC-SEMI

Bonet, L. Almenar, Gonzalez-Franco, A.

Article. 10.1016/j.rce.2020.11.009. 2022

Consensus on the management of hyperkalemia in patients with heart failure: Recommendations from the SEC-SEMI.

Almenar Bonet, L, Gonzalez-Franco, A

Article. 10.1016/j.rceng.2020.11.012. 2021

Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano JB; (...); Soto-Ortega I

Article. 10.1016/j.farma.2023.01.003. 2023

Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano, Jose Bruno; (...); Soto-Ortega, Inmaculada

Article. 10.1016/j.farma.2023.04.002. 2023

Conversion From Immediate-Release Tacrolimus to Prolonged-Release Tacrolimus in Stable Heart Transplant Patients: A Retrospective Study

Gonzalez-Vilchez, F; (...); Crespo-Leiro, MG

Article. 10.1016/j.transproceed.2019.04.028. 2019

Correlates of musculoskeletal pain and kinesiophobia in older adults with heart failure: A structural equation model.

Sentandreu-Mano, Trinidad; (...); Marques-Sule, Elena

Article. 10.1016/j.gerinurse.2023.07.003. 2023

COST MINIMIZATION ANALYSIS OF RITUXIMAB BIOSIMILAR VERSUS REFERENCE RITUXIMAB IN THE TREATMENT OF FOLLICULAR LYMPHOMA

Gironella, M.; (...); Oyaguez, I

Meeting Abstract. 2019

COST-EFFECTIVENESS ANALYSIS OF DIFELIKEFALIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE ASSOCIATED-PRURITUS IN SPAIN

Sanchez-Alvarez, Emilio E.; (...); Hernaez Colque, M.

Meeting Abstract. 2024

Cost-effectiveness of Cladribine Tablets and fingolimod in the treatment of relapsing multiple sclerosis with high disease activity in Spain.

Poveda JL; (...); Torres C

Article. 10.1080/14737167.2019.1635014. 2020

COSTS OF THE MANAGEMENT OF HEMOPHILIA A WITH INHIBITORS IN SPAIN

Bonanad, S; (...); Gonzalez-Dominguez, A

Meeting Abstract. 2020

Costs of the management of hemophilia A with inhibitors in Spain

Bonanad, S; (...); Gonzalez-Dominguez, A

Article. 10.33393/grhta.2021.2234. 2021

COVID-19 AND CARDIAC TRANSPLANTATION. EXPERIENCE IN A TERTIARY HOSPITAL

Trenado, VD; (...); Almenar-Bonet, L

Meeting Abstract. 2021

COVID-19 and Heart Transplantation. Initial Experience in a Tertiary Hospital.

Article. 10.1016/j.transproceed.2021.07.054. 2021

COVID-19 infection in heart transplants in pre- and post-vaccination periods

Donoso Trenado, V.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

COVID-19 Infection in Heart Transplants in Pre- and Postvaccination Periods.

Donoso Trenado, Victor; (...); Almenar-Bonet, Luis

Article. 10.1016/j.transproceed.2022.10.005. 2022

Creatinine and NT-ProBNP levels could predict the length of hospital stay of patients with decompensated heart failure.

Article. 10.1080/00015385.2020.1871264. 2021

Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products

Eduardo Megias, Juan; (...); Iorio, Alfonso

Meeting Abstract. 10.1182/blood-2019-127946. 2019

Current Situation and Prognostic Evolution of Combined Heart-lung Transplantation in a European Union Country

Lopez-Vilella, R.; (...); Almenar Bonet, L.

Article. 2022

CURRENT STATUS AND DEVELOPMENT OF CARDIOPULMONARY TRANSPLANTATION IN SPAIN

Lopez-Vilella, R; (...); Almenar-Bonet, L

Meeting Abstract. 2021

Cybersecurity, a priority for pharmacy services in the age of artificial intelligence.

Hernández Marín CM, Monte-Boquet E, Poveda Andrés JL

Editorial Material. 10.1016/j.farma.2024.08.001. 2024

Changes in REVEAL risk score in patients with pulmonary arterial hypertension treated with macitentan in clinical practice: results from the PRACMA study

Escribano-Subias, P; (...); Barbera, JA

Article. 10.1186/s12890-020-01197-5. 2020

Changes in the Treatment of Decompensated Advanced Heart Failure During Hospitalization and at Discharge.

Article. 10.1016/j.transproceed.2022.10.002. 2022

Changes over the years in the indication for heart-lung transplantation in Spain

Lopez Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

De una asistencia biventricular mínimamente invasiva al implante de Heartware.

Pérez-Guillén M; (...); Torregrosa-Puerta S

Article. 10.24875/ACM.21000073. 2022

Depression mediates physical activity readiness and physical activity in patients with heart failure

Deka, Pallav; (...); Marques-Sule, Elena

Article. 10.1002/ehf2.13609. 2021

Design and rationale for a real-world prospective, multicenter registry of myocardial revascularization failure and secondary revascularization: The REVASEC study.

Salinas P; (...); Escaned J

Article. 10.1016/j.carrev.2021.11.015. 2021

Destination Therapy Strategies of Advanced Heart Failure in Elderly Non-Heart Transplant Candidates: A Propensity Matching Analysis from the LEVO-D and REGALAD Registries

Dobarro, David; (...); Gonzalez-Costello, Jose

Article. 10.3390/life14121570. 2024

Determining the value contribution of emicizumab (Hemlibra (R)) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis

Alvarez-Roman, MT; (...); Badia, X

Article. 10.1177/2284240319880534. 2019

DETERMINING THE VALUE OF EMICIZUMAB FOR THE PROPHYLAXIS OF SEVERE HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)

Alvarez, E.; (...); Badia, F. J.

Meeting Abstract. 2019

Determining value in the treatment of activated PI3Kdelta syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.

Abad, Maria Reyes; (...); Gil, Alicia

Article. 10.33393/grhta.2024.3041. 2024

Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis

Silvestre, Juan Francisco; (...); Serra-Baldrich, Esther

Article. 10.1002/jvc2.275. 2024

DEVELOPMENT AND VALIDATION OF A MCDA FRAMEWORK FOR EVALUATION AND DECISION-MAKING OF ORPHAN DRUGS IN SPAIN

Poveda, J. L.; (...); Vitoria, I

Meeting Abstract. 2019

Development and validation of an MCDA framework for evaluation and decision-making of orphan drugs in Spain

Badia, X; (...); Poved, JL

Article. 10.1080/21678707.2019.1652163. 2019

Development, Implementation and Assessment of Molecular Diagnostics by Next Generation Sequencing in Personalized Treatment of Cancer: Experience of a Public Reference Healthcare Hospital.

Simarro J; (...); Palanca S

Article. 10.3390/cancers11081196. 2019

Diagnosis of intraamniotic inflammation by measuring vaginal interleukin-6 in patients with cervical insufficiency: could amniocentesis be avoided?

Diago Muñoz DM; (...); Diago Almela, Vicente Jose

Article. 10.1080/14767058.2022.2029838. 2022

Diagnostic accuracy of C-reactive protein, procalcitonin and neutrophils for the early detection of anastomotic leakage after colorectal resection: a multicentric, prospective study

Sala Hernandez, Angela; (...); Garcia-Granero, Eduardo

Article. 10.1111/codi.15845. 2021

Diagnostic value of serum miR-144-3p for the detection of acute cellular rejection in heart transplant patients.

Perez-Carrillo, Lorena; (...); Rosello-Lleti, Esther

Article. 10.1016/j.healun.2021.10.004. 2022

Does the age of the recipient influence the survival of the heart transplant?

Lopez-Vilella, RLV; (...); Bonet, LABA

Meeting Abstract. 2019

Donor-derived cell-free DNA as a new biomarker for cardiac allograft rejection: A prospective study (FreeDNA-CAR).

Jimenez-Blanco, Marta; (...); Segovia-Cubero, Javier

Article. 10.1016/j.healun.2024.11.009. 2024

Donor-Derived Cell-Free DNA as a Potential Biomarker for Acute Cellular Rejection Surveillance (FreeDNA-CAR Study)

Bravo, M. Jimenez -Blanco; (...); Segovia-Cubero, J.

Meeting Abstract. 2023

Donor-Derived Cell-Free DNA Correlates Well with NT-ProBNP in Heart Transplant Recipients Undergoing Routine Endomyocardial Biopsies During First Year Post-Heart Transplant

Bravo, M. Jimenez-Blanco; (...); Segovia-Cubero, J.

Meeting Abstract. 2023

Donor-Transmitted Coronary Artery Disease in Heart Transplantation: Prevalence and Characteristics in the Real World. Results from the Multicentric Donor Coronary Artery Disease (DONOR-CAD) Study

Couto-Mallon, D.; (...); Crespo-Leiro, M. G.

Meeting Abstract. 2022

Durable ventricular assist device in Spain (2007-2020). First report of the REGALAD registry.

Gomez-Bueno, Manuel; (...); Gonzalez-Costello, Jose

Article. 10.1016/j.rec.2022.07.011. 2022

Efecto de la adición de fortificantes y de módulo de proteínas en la osmolalidad de la leche materna donada.

Torres Martínez E; (...); Vento M

Article. 10.1016/j.anpedi.2020.03.009. 2020

Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment

Palanques-Pastor T; (...); Poveda Andrés JL

Article. 10.1159/000517813. 2021

Effects of COVID-19 Lockdown on Heart Failure Patients: A Quasi-Experimental Study.

Sánchez-González JL; (...); Marques-Sule E

Article. 10.3390/jcm12227090. 2023

Endothelial Biomarkers Are Superior to Classic Inflammatory Biomarkers in Community-Acquired Pneumonia.

González-Jiménez P; (...); Méndez R

Article. 10.3390/biomedicines12102413. 2024

Endothelial Damage, Neutrophil Extracellular Traps and Platelet Activation in COVID-19 vs. Community-Acquired Pneumonia: A Case-Control Study.

González-Jiménez P; (...); Menéndez R

Article. 10.3390/ijms241713194. 2023

EPIDEMIOLOGICAL STUDY OF TRICUSPID REGURGITATION AFTER CARDIAC TRANSPLANTATION. DOES IT INFLUENCE SURVIVAL?

Lopez-Vilella, R; (...); Almenar-Bonet, L

Meeting Abstract. 2021

Epidemiological Study of Tricuspid Regurgitation After Cardiac Transplantation. Does it Influence Survival?

Article. 10.3389/ti.2022.10197. 2022

EVALUATING REAL LIFE CRITERIA THAT COULD DRIVE PRICING & REIMBURSEMENT (P&R) APPROVAL OF ORPHAN DRUGS (ODS) IN SPAIN

Badia, F. J.; (...); Shepherd, J.

Meeting Abstract. 2019

Evaluating the complement C1q levels in serum and cerebrospinal fluid in multiple sclerosis patients: Could it serve as a valuable marker in clinical practice?

Tortosa-Carreres J; (...); Pérez-Miralles FC

Article. 10.1016/j.jneuroim.2024.578428. 2024

Evolutionary description of heart transplantation and heart-lung transplantation in congenital heart disease

Donoso Trenado, V.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

Evolutionary Description of Heart Transplantation and Heart-Lung Transplantation in Congenital Heart Disease.

Donoso Trenado, Victor; (...); Almenar-Bonet, Luis

Article. 10.1016/j.transproceed.2022.10.006. 2022

Evolving Indications for Heart-Lung Transplant in Spain.

Article. 10.1016/j.transproceed.2022.10.003. 2022

Experience with COVID-19 heart transplant patients in a tertiary hospital

Donoso, V.; (...); Almenar Bonet, L.

Article. 2021

Experience with the potassium binder patiromer in hyperkalaemia management in heart failure patients in real life

Esteban-Fernandez, Alberto; (...); Lopez-Vilella, Raquel

Article. 10.1002/ehf2.13976. 2022

EXTENDED MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD EXTENSION STUDY

F, de Andres-Nogales; (...); Martinez, M.

Meeting Abstract. 2019

Facilitators and barriers to perform physical activity in patients post-heart transplantation: a qualitative study.

Klompstra L; (...); Marques-Sule E

Article. 10.1093/eurjcn/zvae144. 2024

Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report

Fernandez-Sanchez, M; (...); Poveda-Andres, JL

Article. 10.1002/bdr2.1942. 2021

Gender Differences in Health-Related Quality of Life in Patients with Systolic Heart Failure: Results of the VIDA Multicenter Study

Garay, A; (...); VIDA-IC Multicenter Study Investig

Article. 10.3390/jcm9092825. 2020

Gender differences in heart transplantation: Twenty-five year trends in the nationwide Spanish heart transplant registry.

García-Cosío MD; (...); Delgado-Jiménez JF

Article. 10.1111/ctr.14096. 2020

Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review.

Plaza J; (...); Moret-Tatay I

Article. 10.3390/ijms25073717. 2024

Golgi ribbon integrity in human patients with chronic heart failure

Gimenez Escamilla, I.; (...); Tarazon, E.

Meeting Abstract. 2021

Guide to Good Humanization Practices in Patients with Rare Diseases. who vadis

Poveda Andres, Jose Luis

Editorial Material. 2022

Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study

Solana-Altabella, Antonio; (...); Martinez-Cuadron, David

Article. 10.3390/cancers14081921. 2022

Heart transplantation and heart-lung transplantation in congenital heart disease. experience in a tertiary referral hospital

Donoso, V.; (...); Almenar Bonet, L.

Meeting Abstract. 2021

High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis.

El-Qutob D; (...); Carrera-Hueso FJ

Article. 10.1016/j.hrtlng.2022.02.003. 2022

High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis.

Castillo-Villalba, Jessica; (...); Casanova, Bonaventura

Article. 10.3389/fimmu.2022.827738. 2022

Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies

Bruno Montoro-Ronsano, Jose; (...); Alberto Vella, Vincenzo

Article. 10.7399/fh.11729. 2022

Hospitalization budget impact during the COVID-19 pandemic in Spain.

Carrera-Hueso, F. J.; (...); Crespo-Palomo, C.

Article. 10.1186/s13561-021-00340-0. 2021

How can artificial intelligence optimize value-based contracting?

Poveda, Jose Luis; (...); Medrano, Ignacio H.

Letter. 10.1186/s40545-022-00475-3. 2022

Hyperkalemia in heart failure patients in Spain and its impact on guidelines and recommendations: ESC-EORP-HFA Heart Failure Long-Term Registry.

Crespo-Leiro, Maria G.; (...); Delgado-Jimenez, Juan

Article. 10.1016/j.recesp.2019.05.004. 2020

Identification of sarcomere serum biomarkers for non-invasive diagnosis of cardiac rejection

Perez Carrillo, L.; (...); Esther Rosello-Lleti, E.

Meeting Abstract. 2021

Immunogenicity of COVID-19 vaccines in lung cancer patients.

Provencio M; (...); Calvo V

Article. 10.1016/j.lungcan.2023.107323. 2023

Impact of Circulatory Assistance in the Early Evolution After Heart Transplantation. Unicentric Experience.

Martinez-Lauwers, Ana; (...); Martinez-Dolz, Luis

Article. 10.1016/j.transproceed.2021.08.041. 2021

Impact of circulatory assistance in the early evolution after heart transplantation: unicentric experience.

Martinez-Lauwers, A.; (...); Martinez-Dolz, L.

Meeting Abstract. 2020

Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.

Megías-Vericat JE; (...); Montesinos P

Article. 10.1080/10428194.2020.1839650. 2020

Impact of donor-recipient age on cardiac transplant survival. Subanalysis of the Spanish Heart Transplant Registry.

Article. 10.1016/j.recesp.2020.02.018. 2020

Impact of intrapatient blood level variability of calcineurin inhibitors on heart transplant outcomes.

González-Vílchez F; (...); Vázquez de Prada JA

Article. 10.1016/j.rec.2021.02.001. 2021

Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction.

Article. 10.1002/ehf2.13753. 2022

Impact of left ventricular unloading on postheart transplantation outcomes in patients bridged with VA-ECMO.

Enríquez-Vázquez D; (...); Crespo-Leiro MG

Article. 10.1016/j.rec.2024.09.005. 2024

Impact of preoperative left ventricular unloading on post-transplant outcomes of candidates bridged with venoarterial extracorporeal membrane oxygenation

Enriquez Vazquez, D.; (...); Crespo-Leiro, M.

Meeting Abstract. 2024

Impact of serum levels variability of calcineurin inhibitors on heart transplant outcomes

Gonzalez-Vilchez, FJFJ; (...); De Prada, JAV

Meeting Abstract. 2019

Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019

Badia X; (...); Hernández C

Article. 10.1186/s13023-020-01507-4. 2020

Impact of voriconazole plasma concentrations on treatment response in critically ill patients

Ruiz, J; (...); Ramirez, P

Article. 10.1111/jcpt.12817. 2019

Impact on Survival of Heart and Heart-Lung Transplantation in Patients With Cyanotic and Noncyanotic Congenital Heart Diseases.

Donoso-Trenado, Victor; (...); Almenar-bonet, Luis

Article. 10.1016/j.transproceed.2024.12.005. 2024

Implementation and results of a risk-sharing scheme for enzyme replacement therapy in lysosomal storage diseases

Edo-Solsona, MD, Vitoria-Minana, I, Poveda-Andres, JL

Article. 10.7399/fh.11262. 2020

Implication of Sphingolipid Metabolism Gene Dysregulation and Cardiac Sphingosine-1-Phosphate Accumulation in Heart Failure.

Perez-Carrillo, Lorena; (...); Tarazon, Estefania

Article. 10.3390/biomedicines10010135. 2022

Implication of sphingolipid metabolism gene dysregulation and cardiac sphingosine-1-phosphate accumulation in heart failure

Perez Carrillo, L.; (...); Tarazon, E.

Meeting Abstract. 2021

Implications of Molecular Markers in Brain-Dead Donors in Primary Graft Dysfunction and Rejection After Heart Transplantation: The Potential Role of Preconditioning

Herrador-Galindo, L.; (...); Moreno-Gonzalez, G.

Meeting Abstract. 10.1016/j.healun.2024.02.526. 2024

Improvement in left atrial strain following ferric carboxymaltose in heart failure: an analysis of the Myocardial-IRON trial.

Santas E; (...); Núñez J

Article. 10.1002/ehf2.14630. 2023

Improving diuresis and dropsy with elamipretide in advanced heart failure (IDDEA-HF); a multi-centre, double-blind, placebo-controlled trial

Cleland, JGF; (...); Pitt, B

Meeting Abstract. 2019

Incidence and Prognosis of Colorectal Cancer After Heart Transplantation: Data From the Spanish Post-Heart Transplant Tumor Registry

Sagastagoitia-Fornie, Marta; (...); Crespo-Leiro, Maria G.

Article. 10.3389/ti.2023.11042. 2023

Infectious complications associated with short-term mechanical circulatory support in urgent heart transplant candidates.

Solla-Buceta M; (...); Barge-Caballero E

Article. 10.1016/j.rec.2020.11.019. 2021

Infective endocarditis in patients with heart transplantation.

Martínez-Sellés M; (...); Muñoz P

Article. 10.1016/j.ijcard.2020.12.018. 2021

Influence of Gender in Advanced Heart Failure Therapies and Outcome Following Transplantation.

García-Cosío MD; (...); Delgado JF

Article. 10.3389/fcvm.2021.630113. 2021

Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.

Megías-Vericat JE; (...); Montesinos P

Article. 10.1097/FPC.0000000000000431. 2021

Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction.

Esteban-Fernández A; (...); Ridocci-Soriano F

Article. 10.1007/s00392-023-02241-0. 2024

Influence on kinesiophobia by disability, physical, and behavioural variables after a heart transplantation.

Marques-Sule E; (...); Bäck M

Article. 10.1093/eurjcn/zvab134. 2022

Initial and Residual Cardiovascular Damage Remaining at Day 30 in Community-acquired Pneumonia

Ocana, R. Mendez; (...); Menendez, R.

Meeting Abstract. https://doi.org/10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A6241. 2024

Intraperitoneal vancomycin in neonates during peritoneal dialysis: A case report

Company-Albir, MJ; (...); Poveda, JL

Article. 10.1111/jcpt.12842. 2019

Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.

Solana-Altabella A; (...); Poveda JL

Article. 10.1177/1078155220904410. 2020

Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19

Palanques-Pastor, T, Lopez-Briz, E, Andres, JLP

Article. 10.1136/ejhpharm-2020-002322. 2020

Iron deficiency and short-term adverse events in patients with decompensated heart failure.

Palau P; (...); Núñez J

Article. 10.1007/s00392-021-01832-z. 2021

Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.

Pozo-Rosich P; (...); Irimia P

Article. 10.1186/s10194-024-01747-w. 2024

Is the Benefit of Treating Iron Deficiency Greater in Acute Heart Failure with Renal Dysfunction?

Lopez-Vilella, Raquel; (...); Almenar Bonet L

Article. 10.3390/life13040915. 2023

Is the benefit of treating iron deficiency greater in acute heart failure with renal dysfunction?

Lopez Vilella, R. Raquel; (...); Bonet, L. Almenar

Meeting Abstract. 2023

Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.

Martin-Cerezuela, Maria; (...); Ramirez Galleymore, Paula

Article. 10.3390/antibiotics13080706. 2024

Kinesiophobia and associated variables in patients with heart failure.

Sentandreu-Mano, Trinidad; (...); Marques-Sule, Elena

Article. 10.1093/eurjcn/zvad072. 2023

Kinesiophobia in heart transplantation patients: a cross-sectional study with a special focus in sex differences

Moreno Segura, N.; (...); Marques-Sule, E.

Meeting Abstract. 2023

Kinesiophobia, physical activity and quality of life in patients with heart failure: a cross-sectional study

Sempere-Rubio, N.; (...); Marques-Sule, E.

Meeting Abstract. 2022

Long-term study of prevalence and evolution of tricuspid regurgitation after orthotopic heart transplantation

Lopez Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

Malignancy after Heart Transplantation: Difference in incidence and prognosis between genders. Data from the Spanish post-Heart Transplant Tumor Registry

Minguito Carazo, C.; (...); Crespo-Leiro, M. G.

Meeting Abstract. 2019

Malignancy following Heart Transplantation: Differences in Incidence and Prognosis between Sexes.

Minguito-Carazo C; (...); Crespo-Leiro MG

Article. 10.1111/tri.13827. 2021

Management of flexible cavovarus foot in patients with Charcot-Marie-Tooth disease: midterm results.

Megías-Vericat JE; (...); Poveda-Andrés JL

Article. 2021

Manipulación de fármacos para su administración por gastrostomía endoscópica percutánea en pacientes con esclerosis lateral amiotrófica y nutrición enteral.

Vázquez Polo A; (...); Vázquez Costa JF

Article. 10.20960/nh.03946. 2022

Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A

Bonanad, S; (...); Santos, S

Article. 10.1007/s12325-021-01853-0. 2021

Mechanical circulatory support in severe primary graft dysfunction: Peripheral cannulation but not earlier implantation improves survival in heart transplantation.

Olivella, Aleix; (...); Gonzalez-Costello, Jose

Article. 10.1016/j.healun.2023.03.008. 2023

Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.

Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor

Article. 10.3390/cancers14030596. 2022

Metyrapone as treatment in the neonatal McCune-Albright syndrome

de Mingo, Carmen; (...); Garcia-Robles, Ana

Article. 10.1515/jpem-2020-0036. 2020

Monitoring coagulation factors during surgery. A systematic review

Eduardo Megias-Vericat, Juan; (...); Luis Poveda-Andres, Jose

Review. 10.7399/fh.11766. 2021

Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH).

Valero-García S; (...); Delgado-Sánchez O

Article. 10.7399/fh.11655. 2021

Mortality after the first hospital admission for acute heart failure de novo vs. acutely decompensated heart failure with reduced ejection fraction

Lopez Vilella, R. Raquel; (...); Almenar Bonet, L.

Meeting Abstract. 2023

Mortality After the First Hospital Admission for Acute Heart Failure, De Novo Versus Acutely Decompensated Heart Failure With Reduced Ejection Fraction.

Article. 10.1016/j.amjcard.2023.03.008. 2023

Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments

Gomez-Cebrian, N; (...); Pineda-Lucena, A

Review. 10.3390/cancers13184544. 2021

Musculoskeletal disorders in men and women with heart transplantation. A cross-sectional study

Segura, N. Moreno; (...); Marques-Sule, E.

Meeting Abstract. 2023

National Survey of the SEFH-2019: portfolio of services, healthcare activity, teaching and research in Hospital Pharmacy Services in Spain (vol 45, pg 32, 2021)

Perez-Encinas, Montserrat; (...); Angel Calleja-Hernandez, Miguel

Correction. 10.7399/fh.11740. 2021

National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies

Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis

Meeting Abstract. 10.1182/blood-2022-169938. 2022

Neutrophil Extracellular Traps and Platelet Activation for Identifying Severe Episodes and Clinical Trajectories in COVID-19

González-Jiménez P; (...); Menéndez R

Article. 10.3390/ijms24076690. 2023

New challenges of advanced therapies.

Megías-Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.farma.2023.11.008. 2024

No Obesity Paradox for Health-Related Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Insights from the VIDA Multicenter Study

Cassado-Valls, Paula; (...); Comin-Colet, Josep

Article. 10.3390/jcm13247558. 2024

Non-invasive diagnosis of cardiac rejection using small non-coding RNAs

Gimenez-Escamilla, I.; (...); Rosello-Lleti, E.

Meeting Abstract. 2022

Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial-IRON Trial.

Núñez J; (...); Bayés-Genís A

Article. 10.1161/JAHA.119.014254. 2020

Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus

Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis

Article. 10.1097/MD.0000000000032208. 2022

ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.

Poveda JL; (...); Badia X

Article. 10.1186/s13023-022-02610-4. 2023

Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes

Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor

Review. 10.3390/biology12091159. 2023

OPTIMIZING MANAGEMENT AND OUTCOMES OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS) IN SPAIN: BEWAYAPDS PROJECT

Flores-Moreno, S.; (...); Gil, A.

Meeting Abstract. 2024

Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol

Garcia-Robles, Ana; (...); Carrascosa, MA

Article. 10.3389/fped.2020.00372. 2020

Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol (vol 8, 372, 2020)

Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta

Correction. 10.3389/fped.2021.834454. 2022

Particularities of foundational therapy in patients with newly diagnosed heart failure and reduced LVEF secondary to tachycardiomyopathy

Esteban Fernandez, A. Alberto; (...); De Juan Baguda, J.

Meeting Abstract. 2024

Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project

Morillo-Verdugo, R; (...); Diaz-Olmo, J

Article. 10.7399/fh.11719. 2021

Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project.

Morillo-Verdugo R; (...); Díaz-Olmo J

Article. 2021

Percutaneous biventricular mechanical assistance as a bridge to heart transplant.

Perez-Guillen, Manuel; (...); Martinez-Leon, Juan B

Case Reports. 10.1016/j.rec.2023.07.007. 2023

Periodontal disease and gestational diabetes mellitus: a case-control study

Estevez Llorens, R.; (...); Perales Marin, A.

Article. 10.1016/j.gine.2021.100675. 2021

Peripheral access ultrafiltration as a treatment for cardiorenal syndrome with inadequate diuretic response. Initial experience

Letter. 10.1016/j.recesp.2022.04.017. 2023

Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy

Margusino-Framiñán L; (...); Morillo-Verdugo R

Article. 10.7399/fh.11498. 2020

Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.

Ballesta-Lopez, Octavio; (...); Poveda-Andres, Jose Luis

Article. 10.3390/ijms26041760. 2025

Pharmacometabolomics by NMR in Oncology: A Systematic Review.

Gómez-Cebrián N; (...); Pineda-Lucena A

Article. 10.3390/ph14101015. 2021

Pharmacotherapeutic management of advanced therapy medicinal products

Luis Poveda-Andres, Jose; (...); Valero-Garcia, Silvia

Article. 10.7399/fh.13036. 2022

Physical activity enjoyment, exercise motivation, and physical activity in patients with heart failure: A mediation analysis.

Klompstra L; (...); Marques-Sule E

Article. 10.1177/02692155221103696. 2022

Physical activity readiness in patients with heart failure

Klompstra, L; (...); Almenar, L

Meeting Abstract. 2020

PK-GUIDED SWITCH BETWEEN STANDARD HALF-LIFE AND EXTENDED HALF-LIFE FACTOR VIII PRODUCTS

Vericat, JEM; (...); Iorio, A

Meeting Abstract. 2020

Plasma Levels of SERCA2a as a Noninvasive Biomarker of Primary Graft Dysfunction After Heart Transplantation.

Lozano-Edo S; (...); Martínez-Dolz L

Article. 10.1097/TP.0000000000003798. 2021

Practical Requirements for the Development of an Advanced Cardiorenal Unit

Almenar-Bonet, Luis; (...); Sanchez-Perez, Pilar

Review. 10.1159/000536104. 2024

Predicting Sarcopenia and Frailty Risk in Patients Post Heart Transplantation.

Sentandreu-Mano, Trinidad; (...); Machado, Felipe V C

Article. 10.1111/ctr.70027. 2025

Predictive potential of serum and cerebrospinal fluid biomarkers for disease activity in treated multiple sclerosis patients.

Tortosa-Carreres J; (...); Pérez-Miralles FC

Article. 10.1016/j.msard.2024.105734. 2024

Predictive Value of First Amniotic Sac IL-6 and Maternal Blood CRP for Emergency Cerclage Success in Twin Pregnancies.

Diago-Munoz, Diana Maria; (...); Diago-Almela, Vicente Jose

Article. 10.3390/jpm15010037. 2025

PRELIMINAR STUDY OF THERAPY ADHERENCE CONTROLLED BY PRESCRIPTION OF MEDICATION AND SELF-PERCEPTION ADHERENCE OF INFLAMMATORY CHRONIC DISEASE PATIENTS

Garcia, EG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.5937. 2019

Preliminary experience on the usefulness of immunoglobulin A as a biomarker in patients with decompensated heart failure

Lopez-Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2021

Preparación y administración de perfusiones de insulina en neonatología: Encuesta nacional.

García-Robles A; (...); Aguar-Carrascosa M

Letter. 10.1016/j.anpedi.2020.06.008. 2021

Preparation and administration of insulin infusions in neonatology: A national survey.

Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta

Article. 10.1016/j.anpede.2020.06.015. 2021

Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy Services

Company Albir MJ, Poveda Andrés JL, Edo Solsona MD

Article. 10.1016/j.farma.2023.06.0131130. 2024

Prevalence of Tricuspid Regurgitation After Orthotopic Heart Transplantation and Its Evolution in the Follow-up Period: A Long-Term Study.

Article. 10.1016/j.transproceed.2022.09.009. 2022

Prevalence, characteristics, and phenotype associated with tachycardiomyopathy in a cohort of patients first hospitalized for heart failure with reduced ejection fraction

Otero Garcia, O.; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. 2024

Prevalence, Characteristics, and Prognostic Relevance of Donor-Transmitted Coronary Artery Disease in Heart Transplant Recipients.

Couto-Mallón D; (...); Crespo-Leiro MG

Article. 10.1016/j.jacc.2023.06.016. 2023

Prevalence, Incidence, and Outcomes of Hyperkalaemia in Patients with Chronic Heart Failure and Reduced Ejection Fraction from a Spanish Multicentre Study: SPANIK-HF Design and Baseline Characteristics.

Delgado-Jimenez, Juan F.; (...); Crespo-Leiro, Maria G.

Article. 10.3390/jcm11051170. 2022

Proactive therapeutic drug monitoring and pharmacogenetic analysis in inflammatory bowel disease: A systematic review

Ballesta-Lopez, Octavio; (...); Luis Poveda-Andres, Jose

Review. 10.7399/fh.11780. 2021

Prognosis after heart transplant in patients with hypertrophic and restrictive cardiomyopathy. A nationwide registry analysis.

Urbistondo, Francisco Gonzalez; (...); De Prada, Jose Antonio Vazquez

Article. 10.1016/j.rec.2023.10.006. 2023

Prognostic determinants in patients with heart failure with reduced ejection fraction after a first hospitalisation for acute heart failure. COMFE registry

Vega, D. Garcia; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. 10.1093/eurheartj/ehae666.1187. 2024

Prognostic determinants in patients with heart failure with reduced ejection fraction after a first hospitalisation for acute heart failure. implications for their clinical management. COMFE registry

Garcia Vega, D. David; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. https://doi.org/10.1093/eurheartj/ehae666.1187. 2024

Prognostic implications of hypo and hyperkalaemia in acute heart failure with reduced ejection fraction. Analysis of cardiovascular mortality and hospital readmissions.

Laymito-Quispe RDP; (...); Almenar-Bonet, Luis

Article. 10.1016/j.medcli.2021.03.037. 2022

Real world comparison of spironolactone and eplerenone in patients with heart failure.

Pardo-Martinez, Patricia; (...); Crespo-Leiro, Maria G

Article. 10.1016/j.ejim.2021.12.027. 2022

Relaxin mimetic in pulmonary hypertension associated with left heart disease: Design and rationale of Re-PHIRE.

Ufnal, Marcin; (...); Rosenkranz, Stephan

Article. 10.1002/ehf2.15203. 2025

Repetitive ambulatory doses of levosimendan as a bridge to heart transplant: patients characteristics and prescription patterns from the LEVO-T Registry.

De Juan Baguda, J.; (...); Gonzalez Costello, J.

Meeting Abstract. 2022

Repetitive ambulatory doses of levosimendan for patients as bridge to heart transplant. Findings from the LEVO-T registry.

De Juan Baguda, J. Javier; (...); Gonzalez-Costello, J.

Meeting Abstract. 2022

Repetitive ambulatory levosimendan as a bridge to heart transplantation.

Baguda, Javier De Juan; (...); Gonzalez-Costello, Jose

Article. 10.1016/j.rec.2023.07.002. 2023

Results of heart retransplantation: subanalysis of the Spanish Heart Transplant Registry

Salterain-Gonzalez, Nahikari; (...); Gonzalez-Vilchez, Francisco

Article. 10.1016/j.recesp.2021.06.010. 2022

Results of heart retransplantation: subanalysis of the Spanish Heart Transplant Registry.

Salterain-Gonzalez, Nahikari; (...); Gonzalez-Vilchez, Francisco

Article. 10.1016/j.rec.2021.06.009. 2021

Revascularization of Donor Transmitted Coronary Artery Disease After Heart Transplantation: Impact on Survival and Cardiovascular Events. Insights from the DONOR-CAD Study

Couto-Mallon, D.; (...); Crespo-Leiro, M. G.

Meeting Abstract. 2023

Review of the allocation criteria for heart transplant in Spain in 2023 . SEC-Heart Failure Association/ONT/SECCE consensus document

González-Costello J; (...); Domínguez-Gil B

Review. 10.1016/j.rec.2023.11.001. 2024

Role of DNMT3B system in human ischemic hearts

Perez Carrillo, L.; (...); Rosello-Lleti, E.

Meeting Abstract. 2021

Role of vericiguat in management of patients with heart failure with reduced ejection fraction after worsening episode.

Olivella, Aleix; (...); Facila Rubio, Lorenzo

Article. 10.1002/ehf2.14647. 2023

Sarcomere ACTC1 and MYO18A serum expression levels detect acute cellular rejection in cardiac transplant patients

Perez Carrillo, L.; (...); Rosello-Lleti, E.

Meeting Abstract. 2021

SEFH National Survey-2019: general characteristics, staffing, material resources and information systems in Spain's hospital pharmacy departments.

Pérez-Encinas M; (...); Calleja-Hernández MÁ

Article. 10.7399/fh.11565. 2020

Serum uric acid and outcomes in patients with chronic heart failure through the whole spectrum of ejection fraction phenotypes: Analysis of the ESC-EORP Heart Failure Long-Term (HF LT) Registry

Ambrosio, Giuseppe; (...); Maggioni, Aldo P.

Article. 10.1016/j.ejim.2021.04.001. 2021

Severity of Donor Transmitted Coronary Artery Disease and Survival after Heart Transplantation. Results from the Donor Coronary Artery Disease (DONOR-CAD) Study

Couto-Mallon, D.; (...); Crespo-Leiro, M. G.

Meeting Abstract. 2023

Sex, Temporary Mechanical Circulatory Support, and HeartTransplantation: Insights From a Multi-Institutional SpanishRegistry.

Enriquez-Vazquez, Daniel; (...); Crespo-Leiro, Maria G.

Letter. 10.1016/j.jchf.2023.07.027. 2023

Short-term changes in left and right systolic function following ferric carboxymaltose: a substudy of the Myocardial-IRON trial.

Santas E; (...); Núñez J

Article. 10.1002/ehf2.13053. 2020

Short-Term Changes in Left and Right Ventricular Cardiac Magnetic Resonance Feature Tracking Strain Following Ferric Carboxymaltose in Patients With Heart Failure: A Substudy of the Myocardial-IRON Trial.

Del Canto I; (...); Núñez J

Article. 10.1161/JAHA.121.022214. 2022

Short-term changes in left and right ventricular CMR feature tracking strain following ferric carboxymaltose in patients with heart failure: a substudy of the Myocardial-IRON trial

Del Canto Serrano, I.; (...); Nunez, J. V.

Meeting Abstract. 2021

Simultaneous Depression of Immunological Synapse and Endothelial Injury is Associated with Organ Dysfunction in Community-Acquired Pneumonia

Menendez, R; (...); Bermejo-Martin, JE

Article. 10.3390/jcm8091404. 2019

Sinus rhythm restoration as an independent predictor of left ventricular ejection fraction improvement in patients with the first hospitalization for heart failure and reduced ejection fraction

Otero Garcia, O. Oscar; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. https://doi.org/10.1093/eurheartj/ehae666.836. 2024

Sinus rhythm restoration as an independent predictor of left ventricular ejection fraction improvement in patients with the first hospitalization for heart failure and reduced ejection fraction

Garcia, O. Otero; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. 10.1093/eurheartj/ehae666.836. 2024

SMPTall man lettering application in medication information systems as a quality and safety strategy in hospital organization

Iglesias Gomez, Ruben; (...); Poveda Andres, Jose Luis

Article. 10.1111/jcpt.13703. 2022

Sodium-glucose cotransporter 2 inhibitors reduce cardiovascular events in acute heart failure. A real-world analysis.

Article. 10.1016/j.ejim.2022.06.008. 2022

Spanish Heart Transplant Registry. 30th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure (1984-2018)

Gonzalez-Vilchez, F; (...); Abella-Anton, R

Article. 10.1016/j.rec.2019.09.005. 2019

Spanish Heart Transplant Registry. 31th Official Report of the Heart Failure Association of the Spanish Society of Cardiology

Gonzalez-Vilchez, F; (...); Casasnovas, IS

Article. 10.1016/j.recesp.2020.06.024. 2020

Spanish Heart Transplant Registry. 31th Official Report of the Heart Failure Association of the Spanish Society of Cardiology.

González-Vilchez F; (...); Groba Marco MDV

Article. 10.1016/j.rec.2020.06.035. 2020

Spanish Heart Transplant Registry. 32nd Official Report of the Heart Failure Association of the Spanish Society of Cardiology

Gonzalez-Vilchez, Francisco; (...); Jesus Valero-Masa, Maria

Article. 10.1016/j.recesp.2021.06.012. 2021

Spanish Heart Transplant Registry. 32nd Official Report of the Heart Failure Association of the Spanish Society of Cardiology.

Gonzalez-Vilchez, Francisco; (...); Valero-Masa, Maria Jesus

Article. 10.1016/j.rec.2021.08.001. 2021

Spanish heart transplant registry. 33rd official report of the Heart failure Association of the Spanish Society of Cardiology.

González-Vílchez F; (...); García-Romero E

Article. 10.1016/j.rec.2022.06.011. 2022

Spanish heart transplant registry. 34th official report of the Heart Failure Association of the Spanish Society of Cardiology.

González-Vílchez F; (...); García-Romero E

Article. 10.1016/j.rec.2023.06.013. 2023

Spanish heart transplant registry. 35th official report of the Heart Failure Association of the Spanish Society of Cardiology.

González-Vílchez F; (...); García-Romero E

Article. 10.1016/j.rec.2024.05.015. 2024

Spanish multicenter study on the monitoring and incidence of hyperkalaemia in patients with heart failure and reduced ejection fraction. SPANIK-HF

Crespo-Leiro, M.; (...); Delgado-Jimenez, J. F.

Meeting Abstract. 2022

Specific test panels for patients with heart failure: implementation and use in the Spanish National Health System

Almenar Bonet, Luis; (...); Generosa Crespo-Leiro, Andmaria

Article. 10.1515/almed-2022-0006. 2022

Study design and rationale of the pAtients pResenTing with cOngenital heaRt dIseAse Register (ARTORIA-R)

Sinning, Christoph; (...); Kirchhof, Paulus

Article. 10.1002/ehf2.13574. 2021

Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia

Megías-Vericat JE; (...); Montesinos P

Review. 10.3390/pharmaceutics14040878. 2022

Systemic Inflammation during and after Bronchiectasis Exacerbations: Impact ofPseudomonas aeruginosa

MENENDEZ, R; (...); Torres, A

Article. 10.3390/jcm9082631. 2020

Technology usage, interest and preferences about technology-based cardiac rehabilitation programmes in heart failure

Sempere-Rubio, N.; (...); Marques-Sule, E.

Meeting Abstract. 2022

Technology Usage, Physical Activity, and Motivation in Patients With Heart Failure and Heart Transplantation.

Deka P; (...); Marques-Sule E

Article. 10.1097/CIN.0000000000001049. 2023

Temporal trends in the use and outcomes of temporary mechanical circulatory support as a bridge to cardiac transplantation in Spain. Final report of the ASIS-TC study.

Barge-Caballero, Eduardo; (...); Crespo-Leiro, Maria G.

Article. 10.1016/j.healun.2022.10.020. 2022

The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity

Garcia-Robles, Ana; (...); Saenz Gonzalez, Pilar

Article. 10.1007/s00431-022-04628-z. 2022

The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.

Gil-Nagel A; (...); Gil A

Article. 10.1016/j.yebeh.2022.108711. 2022

The Female Sex Confers Different Prognosis in Heart Failure: Same Mortality but More Readmissions.

Article. 10.3389/fcvm.2021.618398. 2021

The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).

Badia, Xavier; (...); Valles, Joan-Antoni

Article. 10.1186/s13023-024-03324-5. 2024

Therapeutic approach in heart failure with poor diuretic response. Peripheral ultrafiltration vs. conventional treatment

Lopez-Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2023

Therapeutic approach in heart failure with poor diuretic response: peripheral ultrafiltration vs. conventional treatment.

Article. 10.1002/ehf2.14386. 2023

Three cases of psychosis after use of sacubitril/valsartan.

Perez-Rosello, Victor; (...); Almenar-Bonet, Luis

Letter. 10.1016/j.recesp.2020.05.019. 2021

Topiramate pharmacokinetics in neonates undergoing therapeutic hypothermia and proposal of an optimised dosing schedule.

Marques MR; (...); Mangas-Sanjuan V

Article. 10.1111/apa.14944. 2020

Towards a symbiotic relationship between big data, artificial intelligence, and hospital pharmacy

Del Rio-Bermudez, C; (...); Poveda, JL

Editorial Material. 10.1186/s40545-020-00276-6. 2020

Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.

Chovi-Trull, Maria; (...); Poveda-Andres, Jose Luis

Article. 10.1136/ejhpharm-2024-004184. 2024

Transient pulmonary nodules with halo sign in patients with advanced heart failure: a report of two cases.

López-Vilella R; (...); Bonet LA

Article. 10.1016/j.clinimag.2019.11.008. 2020

Ultrafiltracion de acceso periferico como tratamiento del sindrome cardiorrenal con insuficiente respuesta diuretica. Experiencia inicial.

Art Exhibit Review. 10.1016/j.rec.2022.04.013. 2022

Uncontrolled asistole donation. Impact on primary graft failure and heart transplantation survival

Donoso Trenado, V.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

Undetectable levels of adalimumab in clinical practice: Should we say goodbye to the drug?

Bejar, S; (...); Mateu, PN

Meeting Abstract. 2020

Unveiling the prognostic journey: renal function trajectories in 'de novo' heart failure with reduced ejection fraction - insights from a cohort study and their impact on patient outcomes

Garcia, O. Otero; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. 10.1093/eurheartj/ehae666.835. 2024

Use of a surgically implanted, extracorporeal continuous flow circulatory support system as a bridge to heart transplantation

Cabezon Villalba, G. Gonzalo; (...); Crespo-Leiro, M. G. C. L.

Meeting Abstract. 2023

Use of a surgically implanted, nondischargeable, extracorporeal continuous flow circulatory support system as a bridge to heart transplant.

Villalba, Gonzalo Cabezon; (...); Crespo-Leiro, Maria G

Article. 10.1016/j.rec.2023.05.002. 2024

USE OF CAPLACIZUMAB IN THE ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA

Dominguez Hernandez, L.; (...); Gomez Segui, I

Meeting Abstract. 2019

Use of idarucizumab to reverse the anticoagulant effect of dabigatran in cardiac transplant surgery. a multicentric experience in spain

Crespo-Leiro, MGMG; (...); Almenar-Bonet, L

Meeting Abstract. 2019

Use of Idarucizumab to reverse the anticoagulant effect of dabigatran in cardiac transplant surgery. A multicentric experience in Spain.

Crespo-Leiro MG; (...); Almenar-Bonet L

Article. 10.1111/ctr.13748. 2019

Use of Intra-aortic Balloon Pump as a Bridge to Heart Transplant in Spain: Results From the ASIS-TC Study.

Barge-Caballero, E; (...); Crespo-Leiro, MG

Article. 10.1016/j.rec.2018.07.003. 2019

Usefulness of biomarkers to predict prognosis after heart transplant

Lopez-Vilella, Raquel; (...); Boneta, Luis Almenar

Article. 10.1016/j.rec.2024.04.019. 2024

Usefulness of Immunoglobulin A in Patients With Decompensated Heart Failure: Is It a Future Marker of Congestion? Preliminary Experience.

Article. 10.1016/j.transproceed.2021.07.051. 2021

Usefulness of short-term peripheral ambulatory ultrafiltration in heart failure refractory to diuretics. Initial experience.

Guerrero Cervera B; (...); Almenar Bonet L

Article. 10.1016/j.medcli.2023.04.008. 2023

Usefulness of the biomarker CA125 in the diagnosis of acute cellular rejection in allogeneic heart transplantation

Lopez-Vilella, RLV; (...); Bonet, LABA

Meeting Abstract. 2019

Utility of nucleocytoplasmic transport as a marker in critical heart failure with circulatory assistance as a bridge to transplant

Ezzitouny, M.; (...); Marinez-Dolz, L.

Meeting Abstract. 2020

Utility of the Biomarker CA125 in the Diagnosis of Cellular Rejection in Allogeneic Heart Transplantation.

Lopez-Vilella, R; (...); Bonet, LA

Article. 10.1016/j.transproceed.2021.07.058. 2021

Utility of the IMPACT score for predicting heart transplant mortality. Analysis on a contemporary cohort of the Spanish Heart Transplant Registry

Ortiz-Bautista, Carlos; (...); Delgado-Jimenez, Juan F.

Article. 10.1111/ctr.14774. 2022

Vaccine-carditis study: Spanish multicenter registry of inflammatory heart disease after COVID-19 vaccination.

Pastor Pueyo, Pablo; (...); Worner Diz, Fernando

Article. 10.1007/s00392-023-02225-0. 2023

Validation of miR-181A-5p as a biomarker of acute rejection after heart transplantation. Multicenter study

Crespo-Leiro, M.; (...); Domenech-Garcia, N.

Meeting Abstract. 2023

Validation of the usefulness of 2-dimensional strain parameters to exclude acute rejection after heart transplantation: a multicenter study.

Goirigolzarri Artaza, Josebe; (...); Segovia Cubero, Javier

Article. 10.1016/j.recesp.2020.01.033. 2020

VALUE CRITERIA FOR OUTCOMES BASED MANAGED ENTRY AGREEMENT OF CAR-T IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) THROUGH MCDA

Poveda, J. L.; (...); Lizan, L.

Meeting Abstract. 2023

Value of SERCA2a as a Biomarker for the Identification of Patients with Heart Failure Requiring Circulatory Support.

Ezzitouny M; (...); Martínez-Dolz L

Article. 10.3390/jpm11111122. 2021

Variation in diuretic requirement after peripheral ultrafiltration in heart failure with diuretic resistance

Lopez Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

Variations in the medical treatment of heart failure during admission for decompensation

Lopez Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

Venoarterial extracorporeal membrane oxygenation with or without simultaneous intra-aortic balloon pump support as a direct bridge to heart transplantation: results from a nationwide Spanish registry.

Barge-Caballero G; (...); Barge-Caballero E

Article. 10.1093/icvts/ivz155. 2019

Well-Being, Physical Activity, and Social Support in Octogenarians with Heart Failure during COVID-19 Confinement: A Mixed-Methods Study

Marques-Sule, Elena; (...); Luis Cabanillas-Garcia, Juan

Article. 10.3390/ijerph192215316. 2022

What clinical parameters are associated with the prescription at hospital discharge of all medications with prognostic improvement? Analysis in de novo heart failure with reduced ejection fraction

Lopez Vilella, R. Raquel; (...); Bonet, Almenar

Meeting Abstract. 2024

What factors are associated with myocardial recovery following admission for acute heart failure? Study in patients with de novo diagnosis and reduced left ventricular ejection fraction

Donoso Trenado, V.; (...); Almenar-Bonet, L.

Meeting Abstract. 2024

What motivates heart transplantation patients to exercise and engage in physical activity? A network analysis.

Marques-Sule, Elena; (...); Machado, Felipe V C

Article. 10.1093/eurjcn/zvad051. 2023

Why Iron Deficiency in Acute Heart Failure Should Be Treated: A Real-World Clinical Practice Study.